ClearPoint Neuro (CLPT) EBT Margin (2011 - 2026)

ClearPoint Neuro has disclosed EBT Margin across 15 years of filings, most recently posting 78.69% for Q1 2026.

• EBT Margin for Q1 2026 came in at 78.69%, down 789.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 71.46% (down 700.0% YoY), and the FY2025 annual result was 68.93%, down 872.0% from the prior year.
• EBT Margin came in at 78.69% for Q1 2026 at ClearPoint Neuro, down from 74.76% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 54.08% in Q1 2024 to a low of 119.85% in Q2 2023.
• The 5-year median for EBT Margin is 73.75% (2022), against an average of 76.19%.
• Across the five-year window, EBT Margin tumbled 3725 bps in 2023 and surged 6394 bps in 2024, its largest moves.
• ClearPoint Neuro's EBT Margin stood at 86.37% in 2022, then gained by 20 bps to 69.1% in 2023, then decreased by 1 bps to 69.72% in 2024, then slipped by 7 bps to 74.76% in 2025, then dropped by 5 bps to 78.69% in 2026.
• The last three EBT Margin figures came in at 78.69% (Q1 2026), 74.76% (Q4 2025), and 66.39% (Q3 2025), per Business Quant data.